AzurRx BioPharma - Home

Clinical Publications

“A Phase 2, Open-Label, Multicenter, 2x2 Crossover Trial to Assess the Safety and Efficacy of MS1819-SD in Patients with Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis”.  Konstan M, McBennett K, Boas S, Mazurek H, Gangal M, Srinivasan D, Pennington J. 2020 Digestive Disease Week (DDW) Presentation.

“Impact of a spray dried recombinant lipase, MS1819, For the treatment of exocrine pancreatic insufficiency in patients with chronic pancreatitis. Results of a multicenter, Phase II, open-label, non-randomized study”. Nguyen, N, Lebreton, L, Smith G, Jais P, Schue M, Spoor, T. 2019 Digestive Disease Week (DDW) Presentation.

“Yarrowia lipolytica Lipase 2 is Stable and Highly Active in Test Meals and Increases Fat Absorption in an Animal Model of Pancreatic Exocrine Insuffiency.” Aloulou A, Schué M, Puccinelli D, Milano S, Delchambre C, Leblond Y, Laugier R, Carrière F. Gastroenterology. December 2015. 149(7):1910-1919